Screener / SEC EDGAR /CIK 0001295947 /10-K filed May 14, 2026, compared with May 9, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Prestige Consumer Healthcare Inc. PBH

Compare with peers Embed
Why it changed

The biggest changes in the 10-K filed May 14, 2026, in management's words

10-K, Item 7

This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Operating margin

Big change, FY to Mar 31, 2026 vs Mar 31, 2025

29.6% to 28.4% (-1.2 pts)

The MD&A has no sentence that names a cause for this change.

Net income

Big change, FY to Mar 31, 2026 vs Mar 31, 2025

-11.3%

“The increase in the effective tax rate in 2026 compared to 2025 was primarily due to the mix of earnings in the U.S. and foreign jurisdictions and establishing a taxable presence in a new state.”

Read it in the 10-K

Gross margin

Big change, FY to Mar 31, 2026 vs Mar 31, 2025

55.8% to 54.7% (-1.1 pts)

The MD&A has no sentence that names a cause for this change.

Revenue

Change, FY to Mar 31, 2026 vs Mar 31, 2025

-4.3%

“As a percentage of total revenues, gross profit decreased to 54.7% in 2026 from 55.8% in 2025, primarily due to the decrease in revenue and costs related to the acquisition of our Canadian manufacturing facility.”

Read it in the 10-K

“As a percentage of North American OTC Healthcare revenues, gross profit decreased to 54.8% during 2026 from 55.3% during 2025, primarily due to the decrease in revenue and costs related to the acquisition of our Canadian manufacturing facility.”

Read it in the 10-K

Cash from operations

Change, FY to Mar 31, 2026 vs Mar 31, 2025

+2.4%

“The $6.1 million increase in net cash provided by operating activities was due to the timing of working capital, partially offset by a decrease in net income before non-cash items.”

Read it in the 10-K

“The $2.6 million increase in net cash provided by operating activities was due to an increase in net income before non-cash items, partly offset by increased working capital.”

Read it in the 10-K

What management said, year by year

The cause given in each 10-K, 2 fiscal years, newest first · MD&A (Item 7)

Each bar is how the line changed that year (from the same 10-K's XBRL). Under it, the sentence in that year's MD&A that names the line, a direction and a cause, word for word. A year with no sentence says so.

Revenue

2 of 2 years explained
  • FY 2026 -4.3%

    “As a percentage of total revenues, gross profit decreased to 54.7% in 2026 from 55.8% in 2025, primarily due to the decrease in revenue and costs related to the acquisition of our Canadian manufacturing facility.”

    Read it in the FY 2026 10-K

    “As a percentage of North American OTC Healthcare revenues, gross profit decreased to 54.8% during 2026 from 55.3% during 2025, primarily due to the decrease in revenue and costs related to the acquisition of our Canadian manufacturing facility.”

    Read it in the FY 2026 10-K
  • FY 2025 +1.1%

    “As a percentage of total revenues, gross profit increased to 55.8% in 2025 from 55.5% in 2024, primarily due to an increase in revenue and a decrease in freight costs in our North American OTC Healthcare segment.”

    Read it in the FY 2025 10-K

    “As a percentage of International OTC Healthcare revenues, gross profit increased to 58.1% during 2025 from 57.2% during 2024, primarily due to an increase in revenue and product mix.”

    Read it in the FY 2025 10-K

Gross margin

0 of 2 years explained
  • FY 2026 -1.1 pts

    The FY 2026 MD&A has no sentence that names a cause for this change.

  • FY 2025 +0.3 pts

    The FY 2025 MD&A has no sentence that names a cause for this change.

Operating margin

0 of 2 years explained
  • FY 2026 -1.2 pts

    The FY 2026 MD&A has no sentence that names a cause for this change.

  • FY 2025 -0.8 pts

    The FY 2025 MD&A has no sentence that names a cause for this change.

Net income

2 of 2 years explained
  • FY 2026 -11.3%

    “The increase in the effective tax rate in 2026 compared to 2025 was primarily due to the mix of earnings in the U.S. and foreign jurisdictions and establishing a taxable presence in a new state.”

    Read it in the FY 2026 10-K
  • FY 2025 +2.5%

    “The increase in the effective tax rate in 2025 compared to 2024 was due to the mix of earnings in the U.S. and foreign jurisdictions.”

    Read it in the FY 2025 10-K

Cash from operations

2 of 2 years explained
  • FY 2026 +2.4%

    “The $6.1 million increase in net cash provided by operating activities was due to the timing of working capital, partially offset by a decrease in net income before non-cash items.”

    Read it in the FY 2026 10-K

    “The $2.6 million increase in net cash provided by operating activities was due to an increase in net income before non-cash items, partly offset by increased working capital.”

    Read it in the FY 2026 10-K
  • FY 2025 +1.0%

    “The $2.6 million increase in net cash provided by operating activities was due to an increase in net income before non-cash items, partly offset by increased working capital.”

    Read it in the FY 2025 10-K

    “The $19.2 million increase in net cash provided by operating activities was due to decreased working capital and an increase in net income before non-cash items.”

    Read it in the FY 2025 10-K

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K

Sources

The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.

Also

Financials: the numbers year by year.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.

Next:Accounting checks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.